Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04866862
Status:
UNKNOWN
Last Update Posted:
2022-07-25
First Post:
2021-03-28
Brief Title:
Fruquitinib Combined With Camrelizumab in Non MSI-HdMMR Refractory Colorectal Cancer
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-28
First Submit QC Date:
April 27 2021
Study First Post Date:
2021-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-20
Last Update Post Date:
2022-07-25
Last Update Post Date Type:
ACTUAL